These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24120098)

  • 41. The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression.
    Serrano-Villar S; Gutiérrez C; Vallejo A; Hernández-Novoa B; Díaz L; Abad Fernández M; Madrid N; Dronda F; Zamora J; Muñoz-Fernández MÁ; Moreno S
    J Infect; 2013 Jan; 66(1):57-66. PubMed ID: 23046968
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
    Kuntzen T; Tural C; Li B; Feldmann G; Kupfer B; Nischalke HD; Clotet B; Sauerbruch T; Rockstroh JK; Spengler U
    AIDS; 2008 Jan; 22(2):203-10. PubMed ID: 18097222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
    de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
    HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Current prevalence and characteristics of dermatoses associated with human immunodeficiency virus infection].
    Blanes M; Belinchón I; Merino E; Portilla J; Sánchez-Payá J; Betlloch I
    Actas Dermosifiliogr; 2010 Oct; 101(8):702-9. PubMed ID: 20965013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
    Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
    J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The burden of metabolic diseases amongst HIV positive patients on HAART attending The Johannesburg Hospital.
    Julius H; Basu D; Ricci E; Wing J; Basu JK; Pocaterra D; Bonfanti P
    Curr HIV Res; 2011 Jun; 9(4):247-52. PubMed ID: 21631427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus.
    French AL; Evans CT; Agniel DM; Cohen MH; Peters M; Landay AL; Desai SN
    J Infect Dis; 2013 Aug; 208(4):679-89. PubMed ID: 23687224
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A 12 week longitudinal study of microbial translocation and systemic inflammation in undernourished HIV-infected Zambians initiating antiretroviral therapy.
    Canipe A; Chidumayo T; Blevins M; Bestawros M; Bala J; Kelly P; Filteau S; Shepherd BE; Heimburger DC; Koethe JR
    BMC Infect Dis; 2014 Sep; 14():521. PubMed ID: 25266928
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Markers of Gut Barrier Function and Microbial Translocation Associate with Lower Gut Microbial Diversity in People with HIV.
    Ellis RJ; Iudicello JE; Heaton RK; Isnard S; Lin J; Routy JP; Gianella S; Hoenigl M; Knight R
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct Biomarkers of Microbial Translocation Correlate with Immune Activation in Adult Zambians with Environmental Enteropathy and Hepatosplenic Schistosomiasis.
    Kaonga P; Kaimoyo E; Besa E; Zyambo K; Sinkala E; Kelly P
    Am J Trop Med Hyg; 2017 Nov; 97(5):1603-1610. PubMed ID: 29140241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of circulating bacterial DNA in long-term glucose homeostasis in non-diabetic patients with HIV infection: cohort study.
    Moreno-Pérez Ó; Giner L; Reus S; Boix V; Alfayate R; Frances R; Merino E; Pico A; Portilla J
    Eur J Clin Microbiol Infect Dis; 2018 Feb; 37(2):313-318. PubMed ID: 29197988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.
    Annavajhala MK; Khan SD; Sullivan SB; Shah J; Pass L; Kister K; Kunen H; Chiang V; Monnot GC; Ricupero CL; Mazur RA; Gordon P; de Jong A; Wadhwa S; Yin MT; Demmer RT; Uhlemann AC
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32024712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients.
    Bastard JP; Couffignal C; Fellahi S; Bard JM; Mentre F; Salmon D; Katlama C; Raffi F; Leport C; Capeau J;
    Diabetes Metab; 2019 Dec; 45(6):573-581. PubMed ID: 30862472
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Barriers to ART initiation in HIV infected subjects and with treatment indication in Spain. Why don't they start their treatment? Bridgap Study].
    Viciana-Fernández P; Falcó V; Castaño M; de los Santos-Gil I; Olalla-Sierra J; Hernando A; Deig E; Clotet B; Knobel H; Podzamczer D; Pedrol PD;
    Enferm Infecc Microbiol Clin; 2015; 33(6):397-403. PubMed ID: 25577557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential anti-inflammatory effects of maraviroc in HIV-positive patients: a pilot study of inflammation, endothelial dysfunction, and coagulation markers.
    Francisci D; Falcinelli E; Baroncelli S; Petito E; Cecchini E; Weimer LE; Floridia M; Gresele P; Baldelli F
    Scand J Infect Dis; 2014 Jun; 46(6):466-70. PubMed ID: 24738757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus-Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy.
    Kyosiimire-Lugemwa J; Anywaine Z; Abaasa A; Levin J; Gombe B; Musinguzi K; Kaleebu P; Grosskurth H; Munderi P; Pala P
    J Infect Dis; 2020 Jul; 222(3):381-390. PubMed ID: 31714954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High 25-hydroxyvitamin D is associated with unexpectedly high plasma inflammatory markers in HIV patients on antiretroviral therapy.
    Gangcuangco LMA; Kohorn LB; Chow DC; Keating SM; Norris PJ; Nagamine LS; Ndhlovu LC; Souza SA; Kallianpur KJ; Shikuma CM
    Medicine (Baltimore); 2016 Oct; 95(43):e5270. PubMed ID: 27787390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monocyte activation, but not microbial translocation, is independently associated with markers of endovascular dysfunction in HIV-infected patients receiving cART.
    Pedersen KK; Manner IW; Seljeflot I; Kvale D; Os I; Gerstoft J; Nielsen SD; Trøseid M
    J Acquir Immune Defic Syndr; 2014 Dec; 67(4):370-4. PubMed ID: 25226210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patients.
    Tudesq JJ; Dunyach-Remy C; Combescure C; Doncesco R; Laureillard D; Lavigne JP; Sotto A
    PLoS One; 2017; 12(9):e0183372. PubMed ID: 28934209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered Intestinal Permeability and Fungal Translocation in Ugandan Children With Human Immunodeficiency Virus.
    Dirajlal-Fargo S; El-Kamari V; Weiner L; Shan L; Sattar A; Kulkarni M; Funderburg N; Nazzinda R; Karungi C; Kityo C; Musiime V; McComsey GA
    Clin Infect Dis; 2020 May; 70(11):2413-2422. PubMed ID: 31260509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.